Filing Details
- Accession Number:
- 0001209191-17-053976
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-26 16:29:23
- Reporting Period:
- 2017-09-25
- Accepted Time:
- 2017-09-26 16:29:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
816284 | Celgene Corp | CELG | Pharmaceutical Preparations (2834) | 222711928 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1690298 | Terrie Curran | 86 Morris Avenue Summit NJ 07901 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-09-25 | 1,727 | $143.89 | 3,925 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 599 | Indirect | 401(k) Plan |
Footnotes
- These shares were sold by the reporting person pursuant to a Rule 10b5-1 plan.